abstracts

P060 microRNA-650 Expression in Crohn`s Disease: A Possible Biomarker for Post-Operative Follow-up

P060 microRNA-650 Expression in Crohn's Disease: A Possible Biomarker for Post-Operative Follow-up Best Surgery Abstract

12/10/2020

P039 Factors Associated with Impaired Patient-Reported Outcomes and Work Productivity Among Patients with Crohn’s Disease in Remission

12/10/2020

P038 Factors Associated With Impaired Patient-Reported Outcomes and Work Productivity Among Patients With Ulcerative Colitis in Remission

12/10/2020

P037 Efficacy and Safety of 1-L NER1006 Bowel Preparation in Patients With Inflammatory Bowel Disease: Analysis of 2 Phase 3 Studies

P037 Efficacy and Safety of 1-L NER1006 Bowel Preparation in Patients With Inflammatory Bowel Disease: Analysis of 2 Phase 3 Studies Poppers David1, Oneto Caterina2, Allen Christophe...

12/10/2020

P036 Clinical and psychological factors associated with impaired body image in patients with inflammatory bowel disease

12/10/2020

P035 Decrease in Severity of Psychiatric Comorbidities in the IBD Population During the COVID-19 Pandemic

P035 Decrease in Severity of Psychiatric Comorbidities in the IBD Population During the COVID-19 Pandemic Silfen Alexa1, Rodriguez Tina1, Karpin Jordan1, Traboulsi Cindy1, Rai Victo...

12/10/2020

P034 Rates of Anti-TNF Drug Persistence in Patients with Crohn’s Disease

P034 Rates of Anti-TNF Drug Persistence in Patients with Crohn’s Disease Williams Ted1, Low Robert2, Pop Anca2, Polson Michael1

12/10/2020

P033 Demographic Factors associated with Successful Telehealth Visits in Inflammatory Bowel Disease Patients

12/10/2020

P032 The Symptomatic and Psychological Impacts of COVID-19 Outbreak on IBD Patients – A Patient Survey in a Tertiary Referral Center

P032 The Symptomatic and Psychological Impacts of COVID-19 Outbreak on IBD Patients – A Patient Survey in a Tertiary Referral Center Feng Minjun1, Stone Molly1, Forster Erin1 ...

12/10/2020

P031 Ozanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-year Open-Label Extension

12/10/2020

abstracts

Follow Us on Twitter!

Specialties

Events

Year Round Education

HMP Global Products